Loading clinical trials...

A Study of Fycompa (Perampanel) in Korean Participants | Clinical Trials | Clareo Health

COMPLETEDNCT02722590

A Study of Fycompa (Perampanel) in Korean Participants

The purpose of this post-marketing surveillance is to observe the following items regarding the safety profile of Fycompa (Perampanel) film-coated tablets and oral suspension in normal clinical practi...

Lead sponsor: Eisai Korea Inc.•9 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 1

Investigation of Blood-Brain-Barrier Breakdown Using Manganese Magnetic Resonance Imaging in Drug-Resistant Epilepsy

NCT02531880 · Epilepsy

RECRUITINGNA

The Clinical Utility of BioEP in Diagnostic Decision Making in Epilepsy

NCT06097195 · Epilepsy

RECRUITINGPhase 3

A Study to Test the Long-term Safety and Tolerability of Brivaracetam in Study Participants With Childhood Absence Epilepsy or Juvenile Absence Epilepsy

NCT06315322 · Childhood Absence Epilepsy, Juvenile Absence Epilepsy

RECRUITINGPhase 1/2

A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patients With Drug-resistant Epilepsy

NCT06388707 · Drug Resistant Epilepsy, Epilepsy, and more

RECRUITING

Study for the Diagnosis and Treatment of Drug-resistant Focal Epilepsies

NCT06794606 · Epilepsy

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 9, 2021Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment3,692

Start dateJul 2016

Last updatedAug 9, 2021

Condition

Epilepsy

Locations shown

Chungju, Chungcheong-do

Wŏnju, Gangwon-do

Seongnam, Gyeonggji-do

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 9, 2021Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions